Cannabinoid‐induced reduction in antral pacemaker frequency: a telemetric study in the ferret
Background The gastric myoelectric activity (GMA) is the electrical pacesetter potential, which drives gastric motility. Cannabinoids have broad‐spectrum antiemetic and antinauseant activity. Paradoxically, they inhibit intestinal peristalsis and reduce gastric motility but their effect on GMA rema...
Gespeichert in:
| Veröffentlicht in: | Neurogastroenterology and motility 2010-11, Vol.22 (11), p.1257-e324 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e324 |
|---|---|
| container_issue | 11 |
| container_start_page | 1257 |
| container_title | Neurogastroenterology and motility |
| container_volume | 22 |
| creator | Percie Du Sert, N. Ho, W.‐S. V. Rudd, J. A. Andrews, P. L. R. |
| description | Background The gastric myoelectric activity (GMA) is the electrical pacesetter potential, which drives gastric motility. Cannabinoids have broad‐spectrum antiemetic and antinauseant activity. Paradoxically, they inhibit intestinal peristalsis and reduce gastric motility but their effect on GMA remains unknown.
Methods Ferrets were surgically implanted with radiotelemetry transmitters to record GMA, body temperature and heart rate. The effect of WIN 55,212–2 (1 mg kg−1, i.p.), an agonist at the cannabinoid type 1 and 2 receptors was examined in conscious, unrestrained ferrets. WIN 55,212–2 was also compared to the anandamide upregulator URB 597 (5 mg kg−1, i.p.) for a potential to modulate the emetic response and behavioral changes induced by apomorphine (0.25 mg kg−1, s.c.).
Key Results WIN 55,212–2 decreased GMA frequency (8.1 ± 0.4 cpm, compared to 9.6 ± 0.1 cpm in vehicle‐treated animals, n = 6, P |
| doi_str_mv | 10.1111/j.1365-2982.2010.01581.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_762284776</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>762284776</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3191-a8510973ef79e8d730826b6ace6dd75b9e93b9eb8b7820ddfbad6bf3c2f164763</originalsourceid><addsrcrecordid>eNo9kEtOwzAQhi0EolC4AvKOVYIfje0gsUAVL6nQDawtJ54Il8QtTiKaHUfgjJyEpC2dxcxo5p-HPoQwJTHt7WoRUy6SiKWKxYz0VUITReP1ATrZNw6HPCERTVkyQqd1vSCECDYRx2jEiORUSnmC9NR4bzLnl87-fv84b9scLA7Qx8YtPXYeG98EU-KVyaEyHxBwEeCzBZ9319jgBkqooAkux3XT2m6YaN4BFxACNGfoqDBlDee7OEZv93ev08doNn94mt7OopzTlEZGJZSkkkMhU1BWcqKYyER_UVgrkyyFlPcuU5lUjFhbZMaKrOA5K6iYSMHH6HK7dxWW_W91oytX51CWxsOyrbUUjKmJ3Cgvdso2q8DqVXCVCZ3-Z9ILbraCL1dCt-9Togf2eqEHxHpArAf2esNer_XL83zI-B99NXnE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>762284776</pqid></control><display><type>article</type><title>Cannabinoid‐induced reduction in antral pacemaker frequency: a telemetric study in the ferret</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><creator>Percie Du Sert, N. ; Ho, W.‐S. V. ; Rudd, J. A. ; Andrews, P. L. R.</creator><creatorcontrib>Percie Du Sert, N. ; Ho, W.‐S. V. ; Rudd, J. A. ; Andrews, P. L. R.</creatorcontrib><description>Background The gastric myoelectric activity (GMA) is the electrical pacesetter potential, which drives gastric motility. Cannabinoids have broad‐spectrum antiemetic and antinauseant activity. Paradoxically, they inhibit intestinal peristalsis and reduce gastric motility but their effect on GMA remains unknown.
Methods Ferrets were surgically implanted with radiotelemetry transmitters to record GMA, body temperature and heart rate. The effect of WIN 55,212–2 (1 mg kg−1, i.p.), an agonist at the cannabinoid type 1 and 2 receptors was examined in conscious, unrestrained ferrets. WIN 55,212–2 was also compared to the anandamide upregulator URB 597 (5 mg kg−1, i.p.) for a potential to modulate the emetic response and behavioral changes induced by apomorphine (0.25 mg kg−1, s.c.).
Key Results WIN 55,212–2 decreased GMA frequency (8.1 ± 0.4 cpm, compared to 9.6 ± 0.1 cpm in vehicle‐treated animals, n = 6, P < 0.01). Apomorphine induced 9.0 ± 1.6 emetic episodes, WIN 55,212–2 inhibited the emetic response (3.3 ± 1.0 episodes, n = 6, P < 0.05) but URB 597 had no effect (9.0 ± 1.5 episodes). Apomorphine‐induced hyperactivity in vehicle‐treated animals (6.5 ± 3.6–16.6 ± 4.9 active behavior counts, n = 6, P < 0.01), which was reduced by WIN 55,212–2 (5.0 ± 1.5 counts, n = 6, P < 0.05).
Conclusions & Inferences WIN 55,212–2 demonstrated clear antiemetic efficacy, which extends the broad‐spectrum antiemetic efficacy of cannabinoids to dopamine receptor agonists in the ferret. Our results, however, suggest a more limited spectrum of action for URB 597. WIN 55,212–2 decreased the frequency of the antral electrical pacemaker, which reveals new insights into the mechanism regulating the decrease in motility induced by cannabinoids.</description><identifier>ISSN: 1350-1925</identifier><identifier>EISSN: 1365-2982</identifier><identifier>DOI: 10.1111/j.1365-2982.2010.01581.x</identifier><identifier>PMID: 20731777</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Amidohydrolases - antagonists & inhibitors ; Animals ; Apomorphine ; Benzamides - pharmacology ; Biological Clocks - drug effects ; Body Temperature - drug effects ; cannabinoid ; Cannabinoids - pharmacology ; Carbamates - pharmacology ; emesis ; Emetics ; Female ; Ferrets - physiology ; gastric myoelectric activity ; Heart Rate - drug effects ; Myoelectric Complex, Migrating - drug effects ; Receptor, Cannabinoid, CB1 - agonists ; Receptor, Cannabinoid, CB2 - agonists ; Telemetry ; Vomiting - chemically induced ; Vomiting - prevention & control ; WIN 55,212–2</subject><ispartof>Neurogastroenterology and motility, 2010-11, Vol.22 (11), p.1257-e324</ispartof><rights>2010 Blackwell Publishing Ltd</rights><rights>2010 Blackwell Publishing Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3191-a8510973ef79e8d730826b6ace6dd75b9e93b9eb8b7820ddfbad6bf3c2f164763</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2982.2010.01581.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2982.2010.01581.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20731777$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Percie Du Sert, N.</creatorcontrib><creatorcontrib>Ho, W.‐S. V.</creatorcontrib><creatorcontrib>Rudd, J. A.</creatorcontrib><creatorcontrib>Andrews, P. L. R.</creatorcontrib><title>Cannabinoid‐induced reduction in antral pacemaker frequency: a telemetric study in the ferret</title><title>Neurogastroenterology and motility</title><addtitle>Neurogastroenterol Motil</addtitle><description>Background The gastric myoelectric activity (GMA) is the electrical pacesetter potential, which drives gastric motility. Cannabinoids have broad‐spectrum antiemetic and antinauseant activity. Paradoxically, they inhibit intestinal peristalsis and reduce gastric motility but their effect on GMA remains unknown.
Methods Ferrets were surgically implanted with radiotelemetry transmitters to record GMA, body temperature and heart rate. The effect of WIN 55,212–2 (1 mg kg−1, i.p.), an agonist at the cannabinoid type 1 and 2 receptors was examined in conscious, unrestrained ferrets. WIN 55,212–2 was also compared to the anandamide upregulator URB 597 (5 mg kg−1, i.p.) for a potential to modulate the emetic response and behavioral changes induced by apomorphine (0.25 mg kg−1, s.c.).
Key Results WIN 55,212–2 decreased GMA frequency (8.1 ± 0.4 cpm, compared to 9.6 ± 0.1 cpm in vehicle‐treated animals, n = 6, P < 0.01). Apomorphine induced 9.0 ± 1.6 emetic episodes, WIN 55,212–2 inhibited the emetic response (3.3 ± 1.0 episodes, n = 6, P < 0.05) but URB 597 had no effect (9.0 ± 1.5 episodes). Apomorphine‐induced hyperactivity in vehicle‐treated animals (6.5 ± 3.6–16.6 ± 4.9 active behavior counts, n = 6, P < 0.01), which was reduced by WIN 55,212–2 (5.0 ± 1.5 counts, n = 6, P < 0.05).
Conclusions & Inferences WIN 55,212–2 demonstrated clear antiemetic efficacy, which extends the broad‐spectrum antiemetic efficacy of cannabinoids to dopamine receptor agonists in the ferret. Our results, however, suggest a more limited spectrum of action for URB 597. WIN 55,212–2 decreased the frequency of the antral electrical pacemaker, which reveals new insights into the mechanism regulating the decrease in motility induced by cannabinoids.</description><subject>Amidohydrolases - antagonists & inhibitors</subject><subject>Animals</subject><subject>Apomorphine</subject><subject>Benzamides - pharmacology</subject><subject>Biological Clocks - drug effects</subject><subject>Body Temperature - drug effects</subject><subject>cannabinoid</subject><subject>Cannabinoids - pharmacology</subject><subject>Carbamates - pharmacology</subject><subject>emesis</subject><subject>Emetics</subject><subject>Female</subject><subject>Ferrets - physiology</subject><subject>gastric myoelectric activity</subject><subject>Heart Rate - drug effects</subject><subject>Myoelectric Complex, Migrating - drug effects</subject><subject>Receptor, Cannabinoid, CB1 - agonists</subject><subject>Receptor, Cannabinoid, CB2 - agonists</subject><subject>Telemetry</subject><subject>Vomiting - chemically induced</subject><subject>Vomiting - prevention & control</subject><subject>WIN 55,212–2</subject><issn>1350-1925</issn><issn>1365-2982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtOwzAQhi0EolC4AvKOVYIfje0gsUAVL6nQDawtJ54Il8QtTiKaHUfgjJyEpC2dxcxo5p-HPoQwJTHt7WoRUy6SiKWKxYz0VUITReP1ATrZNw6HPCERTVkyQqd1vSCECDYRx2jEiORUSnmC9NR4bzLnl87-fv84b9scLA7Qx8YtPXYeG98EU-KVyaEyHxBwEeCzBZ9319jgBkqooAkux3XT2m6YaN4BFxACNGfoqDBlDee7OEZv93ev08doNn94mt7OopzTlEZGJZSkkkMhU1BWcqKYyER_UVgrkyyFlPcuU5lUjFhbZMaKrOA5K6iYSMHH6HK7dxWW_W91oytX51CWxsOyrbUUjKmJ3Cgvdso2q8DqVXCVCZ3-Z9ILbraCL1dCt-9Togf2eqEHxHpArAf2esNer_XL83zI-B99NXnE</recordid><startdate>201011</startdate><enddate>201011</enddate><creator>Percie Du Sert, N.</creator><creator>Ho, W.‐S. V.</creator><creator>Rudd, J. A.</creator><creator>Andrews, P. L. R.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201011</creationdate><title>Cannabinoid‐induced reduction in antral pacemaker frequency: a telemetric study in the ferret</title><author>Percie Du Sert, N. ; Ho, W.‐S. V. ; Rudd, J. A. ; Andrews, P. L. R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3191-a8510973ef79e8d730826b6ace6dd75b9e93b9eb8b7820ddfbad6bf3c2f164763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Amidohydrolases - antagonists & inhibitors</topic><topic>Animals</topic><topic>Apomorphine</topic><topic>Benzamides - pharmacology</topic><topic>Biological Clocks - drug effects</topic><topic>Body Temperature - drug effects</topic><topic>cannabinoid</topic><topic>Cannabinoids - pharmacology</topic><topic>Carbamates - pharmacology</topic><topic>emesis</topic><topic>Emetics</topic><topic>Female</topic><topic>Ferrets - physiology</topic><topic>gastric myoelectric activity</topic><topic>Heart Rate - drug effects</topic><topic>Myoelectric Complex, Migrating - drug effects</topic><topic>Receptor, Cannabinoid, CB1 - agonists</topic><topic>Receptor, Cannabinoid, CB2 - agonists</topic><topic>Telemetry</topic><topic>Vomiting - chemically induced</topic><topic>Vomiting - prevention & control</topic><topic>WIN 55,212–2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Percie Du Sert, N.</creatorcontrib><creatorcontrib>Ho, W.‐S. V.</creatorcontrib><creatorcontrib>Rudd, J. A.</creatorcontrib><creatorcontrib>Andrews, P. L. R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Neurogastroenterology and motility</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Percie Du Sert, N.</au><au>Ho, W.‐S. V.</au><au>Rudd, J. A.</au><au>Andrews, P. L. R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cannabinoid‐induced reduction in antral pacemaker frequency: a telemetric study in the ferret</atitle><jtitle>Neurogastroenterology and motility</jtitle><addtitle>Neurogastroenterol Motil</addtitle><date>2010-11</date><risdate>2010</risdate><volume>22</volume><issue>11</issue><spage>1257</spage><epage>e324</epage><pages>1257-e324</pages><issn>1350-1925</issn><eissn>1365-2982</eissn><abstract>Background The gastric myoelectric activity (GMA) is the electrical pacesetter potential, which drives gastric motility. Cannabinoids have broad‐spectrum antiemetic and antinauseant activity. Paradoxically, they inhibit intestinal peristalsis and reduce gastric motility but their effect on GMA remains unknown.
Methods Ferrets were surgically implanted with radiotelemetry transmitters to record GMA, body temperature and heart rate. The effect of WIN 55,212–2 (1 mg kg−1, i.p.), an agonist at the cannabinoid type 1 and 2 receptors was examined in conscious, unrestrained ferrets. WIN 55,212–2 was also compared to the anandamide upregulator URB 597 (5 mg kg−1, i.p.) for a potential to modulate the emetic response and behavioral changes induced by apomorphine (0.25 mg kg−1, s.c.).
Key Results WIN 55,212–2 decreased GMA frequency (8.1 ± 0.4 cpm, compared to 9.6 ± 0.1 cpm in vehicle‐treated animals, n = 6, P < 0.01). Apomorphine induced 9.0 ± 1.6 emetic episodes, WIN 55,212–2 inhibited the emetic response (3.3 ± 1.0 episodes, n = 6, P < 0.05) but URB 597 had no effect (9.0 ± 1.5 episodes). Apomorphine‐induced hyperactivity in vehicle‐treated animals (6.5 ± 3.6–16.6 ± 4.9 active behavior counts, n = 6, P < 0.01), which was reduced by WIN 55,212–2 (5.0 ± 1.5 counts, n = 6, P < 0.05).
Conclusions & Inferences WIN 55,212–2 demonstrated clear antiemetic efficacy, which extends the broad‐spectrum antiemetic efficacy of cannabinoids to dopamine receptor agonists in the ferret. Our results, however, suggest a more limited spectrum of action for URB 597. WIN 55,212–2 decreased the frequency of the antral electrical pacemaker, which reveals new insights into the mechanism regulating the decrease in motility induced by cannabinoids.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>20731777</pmid><doi>10.1111/j.1365-2982.2010.01581.x</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1350-1925 |
| ispartof | Neurogastroenterology and motility, 2010-11, Vol.22 (11), p.1257-e324 |
| issn | 1350-1925 1365-2982 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_762284776 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content |
| subjects | Amidohydrolases - antagonists & inhibitors Animals Apomorphine Benzamides - pharmacology Biological Clocks - drug effects Body Temperature - drug effects cannabinoid Cannabinoids - pharmacology Carbamates - pharmacology emesis Emetics Female Ferrets - physiology gastric myoelectric activity Heart Rate - drug effects Myoelectric Complex, Migrating - drug effects Receptor, Cannabinoid, CB1 - agonists Receptor, Cannabinoid, CB2 - agonists Telemetry Vomiting - chemically induced Vomiting - prevention & control WIN 55,212–2 |
| title | Cannabinoid‐induced reduction in antral pacemaker frequency: a telemetric study in the ferret |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T20%3A03%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cannabinoid%E2%80%90induced%20reduction%20in%20antral%20pacemaker%20frequency:%20a%20telemetric%20study%20in%20the%20ferret&rft.jtitle=Neurogastroenterology%20and%20motility&rft.au=Percie%20Du%20Sert,%20N.&rft.date=2010-11&rft.volume=22&rft.issue=11&rft.spage=1257&rft.epage=e324&rft.pages=1257-e324&rft.issn=1350-1925&rft.eissn=1365-2982&rft_id=info:doi/10.1111/j.1365-2982.2010.01581.x&rft_dat=%3Cproquest_pubme%3E762284776%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=762284776&rft_id=info:pmid/20731777&rfr_iscdi=true |